United States · Biotechnology startup
United States · Metabiota
Metabiota is a provider of field data and risk analytics solutions for organizations to mitigate infectious diseases.
Funding reportedLast round: Series B
What company datasets say Metabiota raised
Funding, as reported
Founders and team
From the SEC filings it signed: 3 on the team.
- Jeremy AlbergaResigned as an executive officer in April 2015.i
- Nathan D WolfeExecutive Officer, Directori
- Robert MannExecutive Officer, Directori
On the board, as filediJohn D DeLocheRiaz Valani
The company, in detail
What they build
Known for
exercise and hormonesdietary strategiessupplement efficacywomen's healthimmune functionmuscle retentionmindful eatinghormone balancemenopausemetabolic healthfat lossdheacardiovascular healthmen's healthmental healthhospital & health care
Built with from their website
Google Tag ManagerLiteSpeedWordPress.orgFont AwesomeCloudFlareViewport MetaGoogle Sign-InAll in One SEOCloudFlare CDNGoogle Identity Services APIs
+8 more
Google Font APIimagesLoadedMySQLPrimeNGMobile FriendlyOpen GraphjQueryRSS
- Sector
- Biotechnology
- Industry code
- NAICS 62139, SIC 8731
- Region
- California
- Part of
- Metabiota (Cameroon)
- Revenue
- $18M a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Metabiota in front of investors. Or tell us what we have wrong.